
0:34
Short educational YouTube monologue by Dr. Charles Mok explaining semaglutide (branded as Ozempic for diabetes and Wegovy for obesity), focusing on its dosing schedule and concepts of drug tolerance/intolerance. The speaker states that maintenance doses can be about ten times higher than early starting doses and that weight loss generally plateaus once maintenance dosing is reached.










